NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









VivoSphere

VivoSphere

Private
Auburn, AlabamaHealthcare & Life Scienceshttps://vivospheres.com/

Last Round

Grant

May 14, 2026

Total Funding Raised

$575,000

Company Overview

VivoSphere is a biotechnology company that develops advanced 3D tissue-engineered models for drug discovery and toxicity testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Hardware Sales

AI Layer

Non-AI

Keywords

3D tissue engineeringpreclinical drug discoveryin vitro modelsorgan-on-a-chiptoxicity testing3D cell culturehigh-throughput screeningcontract research organizationCROdrug screeningmicrospheroidal tissuealternative to animal testingbiotech equipmentassay-ready kitsprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VivoSphere Comparables

Compare VivoSphere with similar companies based on industry and business-model similarity.

VivoSphere comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Obatala Sciences
84%
Altis Biosystems
83%
BiomimX
82%

VivoSphere Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 14, 2026
GrantMay 1, 2025
GrantSep 16, 2024
GrantMay 22, 2024
GrantAug 17, 2023

VivoSphere Investors

Notable investors and investment history

VivoSphere investors
InvestorRounds
NIH RADxGrant
Alabama LaunchpadGrant
National Science FoundationGrant
InvestALGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 16, 2024

    $100K grant received from InvestAL.

VivoSphere Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VivoSphere Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VivoSphere's valuation, stock price, and market status.

Firmographic Details

HeadquartersAuburn, Alabama
Employee Range7
Year Founded2022
Last FundingMay 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.